BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 290 filers reported holding BIONTECH SE in Q1 2022. The put-call ratio across all filers is 1.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,527,743 | -20.0% | 60,086 | -21.3% | 0.01% | -30.0% |
| Q2 2023 | $8,164,100 | +53003.3% | 76,300 | -25.4% | 0.01% | -58.3% |
| Q4 2022 | $15,374 | -99.9% | 102,343 | -8.9% | 0.02% | 0.0% |
| Q3 2022 | $15,016,000 | -13.3% | 112,398 | -7.9% | 0.02% | -17.2% |
| Q2 2022 | $17,319,000 | -44.0% | 121,977 | -31.0% | 0.03% | -27.5% |
| Q1 2022 | $30,908,000 | -70.9% | 176,838 | -57.3% | 0.04% | -68.0% |
| Q4 2021 | $106,243,000 | -11.0% | 413,700 | -3.9% | 0.12% | -7.4% |
| Q3 2021 | $119,438,000 | +87.8% | 430,500 | +54.4% | 0.14% | +36.4% |
| Q2 2021 | $63,589,000 | +327.8% | 278,821 | +95.9% | 0.10% | +371.4% |
| Q1 2021 | $14,863,000 | +90.6% | 142,303 | +53.2% | 0.02% | +75.0% |
| Q4 2020 | $7,799,000 | – | 92,907 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |